h i g h l i g h t s
MS disease type is an independent predictor of dysautonomia. There is a difference in pattern of dysautonomia in pwRRMS and pwPMS. Sweating dysfunction is common in MS, particularly in advanced disease.
a b s t r a c t
Objective: To determine autonomic dysfunction (AD) differences in patients with relapsing remitting multiple sclerosis (pwRRMS) and progressive MS (pwPMS). Methods: Composite autonomic scoring scale (CASS) and heart rate variability (HRV) were performed in 40 pwRRMS and 30 pwPMS. Results: pwPMS had a significantly higher sudomotor index and total CASS score compared to pwRRMS (p < 0.001 and p < 0.001, respectively). Disease duration positively correlated with sudomotor index and total CASS (r s = 0.409, p < 0.001 and r s = 0.472, p < 0.001, respectively), while the Expanded Disability Status Scale (EDSS) positively correlated with sudomotor index and total CASS (r s = 0.411, p < 0.001 and r s = 0.402, p = 0.001, respectively) in all patients. Type of multiple sclerosis (pwRRMS or pwPMS) corrected for age, sex and disease duration, was a statistically significant predictor of CASS value (B = 1.215, p = 0.019). Compared to pwRRMS, pwPMS had a significantly lower standard deviation of NN intervals (SDNN), low frequency (LF), and high frequency (HF), during both the supine and tilt-up phases (all p-values <0.006). pwPMS had a significantly lower LF/HF (p = 0.008) during tilt-up. Conclusion: There is a significant difference in autonomic function in pwRRMS and pwPMS; with pwPMS having a higher burden of AD, which is particularly evident for sweating dysfunction. Significance: Further research is needed to establish whether parasympathetic and sudomotor dysfunction may serve as markers of progressive MS.
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Introduction
Multiple sclerosis (MS) is an idiopathic demyelinating disorder of the central nervous system. It most commonly affects young individuals, between 20 and 40 years-of-age and represents the leading cause of non-traumatic neurologic disability in young adults (Edmonds et al., 2010) . Although the exact etiology is unknown, there is a complex interaction between several environmental factors and a distinct genetic susceptibility which results in demyelinating lesions, the pathological hallmark of MS (Compston and Coles, 2008) . The pathogenesis of the disease is marked by the production of autoreactive lymphocytes that cross the blood-brain barrier and enter into the central nervous system causing demyelination, axonal loss and, ultimately, neurodegeneration (Wu and Alvarez, 2011) .
The natural history of MS seems to be divided into two distinct phases. First is the relapsing-remitting phase, characterized by bouts of acute exacerbation of disease activity. Pathologically, this is correlated with central nervous system (CNS) inflammation. The second phase is determined by a slow but steady progression in neurologic deficit, associated with CNS degeneration (Compston and Coles, 2008) . The differentiation between these two phases
